Covid trial of cholesterol treatment

Scientists at the Hebrew University of Jerusalem successfully trialed TriCor (fenofibrate see here previously) on 15 severely ill Covid patients. 14 were weaned off their ventilators within a week. TriCor targets inflammation-producing lipids produced by the coronavirus.

This entry was posted in Israel's Medical Achievements. Bookmark the permalink.

Leave a Reply

Your email address will not be published.